The successful launch has encouraged an increase in sales projections for the coming years. Furthermore, Zevra Therapeutics is making strategic pipeline investments, with notable progress in the ...

FDA approval of MIPLYFFATM and product launch cap third quarter filled with multiple commercial and clinical development milestones Zevra ...